Publications by authors named "Philippe Chevallier"

Claim this Profile
I
Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.
Joseph Koffi, Romance Egounlety, Pierre Pradat, Fanny Lebosse, Si-Nafa Si-Ahmed, Philippe Chevallier

Eur J Gastroenterol Hepatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
Olivier Borgniet, Parviz Parvaz, Cécile Bouix, Philippe Chevallier, Christian Trépo

J Med Virol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical detection of HCV proteins in liver tissue.
Oivier Galy, Isabelle Vincent, Philippe Chevallier, Nicole Lyandrat, Isabelle Chemin

Methods Mol Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact.
Thomas Walter, Jean-Yves Scoazec, Olivier Guillaud, Valérie Hervieu, Philippe Chevallier

Liver Transpl· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Patrick Miailhes, Mary-Anne Trabaud, Pierre Pradat, Bertrand Lebouché, Michèle Chevallier, Philippe Chevallier

Clin Infect Dis· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins.
Oivier Galy, Marie-Anne Petit, Soumaya Benjelloun, Philippe Chevallier, Michelle Chevallier

Cancer Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful cardiac resynchronization therapy after cardiac surgery.
Maxime Cannesson, Bruno Gostoli, Pascal Rosamel, Claire Flamens, Geneviève Derumeaux, Philippe Chevallier

Anesth Analg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up and management of patients exposed to a flawed automated endoscope washer-disinfector in a digestive diseases unit.
Philippe Vanhems, Angele Gayet-Ageron, Thierry Ponchon, Claude Bernet, Jean-Alain Chayvialle, Philippe Chevallier

Infect Control Hosp Epidemiol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.
Marianne Maynard, Parviz Parvaz, Sandra Durantel, Michèle Chevallier, Philippe Chevallier

J Hepatol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination.
Jérôme Dumortier, Jean-Yves Scoazec, Philippe Chevallier, Olivier Boillot

J Hepatol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
Jérôme Dumortier, Philippe Chevallier, Jean-Yves Scoazec, Françoise Berger, Olivier Boillot

Am J Transplant· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients].
Pierre Rocca, François Bailly, Michèle Chevallier, Philippe Chevallier, Fabien Zoulim

Gastroenterol Clin Biol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV reactivation in the recipient of a liver graft from an anti-HBc positive donor despite post-vaccination antibodies to hepatitis B surface antigen.
Jérôme Dumortier, Philippe Chevallier, Jean-Yves Scoazec, Olivier Boillot

J Hepatol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy.
Nicolas Voirin, Christian Trépo, Jacques Estève, Philippe Chevallier, Jacques Ritter

AIDS· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis